Rheo Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-07-2024
- Paid Up Capital ₹ 0.20 M
as on 06-07-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 37.62%
(FY 2023)
- Profit 136.89%
(FY 2023)
- Ebitda 159.00%
(FY 2023)
- Net Worth 471.62%
(FY 2023)
- Total Assets 811.21%
(FY 2023)
About Rheo Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Lakshmi Yarramreddy and Yarramreddy Reddy serve as directors at the Company.
- CIN/LLPIN
U24299TG2019PTC136445
- Company No.
136445
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2019
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Kukatpally, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rheo Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakshmi Yarramreddy  | Managing Director | 29-Oct-2019 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yarramreddy Reddy | Director | 01-Nov-2020 | Current |
Financial Performance of Rheo Pharma.
Rheo Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 37.62% increase. The company also saw a substantial improvement in profitability, with a 136.89% increase in profit. The company's net worth Soared by an impressive increase of 471.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rheo Pharma?
In 2023, Rheo Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ypr Traders Private LimitedActive 2 years 8 monthsLakshmi Yarramreddy and Yarramreddy Reddy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rheo Pharma?
Unlock and access historical data on people associated with Rheo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rheo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rheo Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
